Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan
With
Stanford University
Johns Hopkins University
Boston University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of heart failure
Last left ventricular ejection fraction within 2 years \< 50% based on echocardiogram, MRI, CT, or nuclear perfusion and, if no ejection fraction documented, then clinical documentation of heart failure with reduced ejection fraction
Currently admitted with upcoming discharge or discharged from hospital within the prior 4 weeks
At least two eligible heart failure therapies (guideline-recommended BB, RASI, MRA, or SGLT2i) not yet initiated or at \< 50% of target dose at time of enrollment
You may not be if
Receives dialysis
Inotropic therapy after hospitalization
History of a prior solid organ transplant or actively listed on heart transplant waiting list
History of left ventricular assist device implantation
Cardiac amyloidosis
Currently pregnant or intends to become pregnant during the study period
Life expectancy estimated less than 6 months related to cardiac or non-cardiac comorbidities as per investigator's judgment
Actively enrolled in hospice or comfort care
Currently participating in an investigational device or drug study or having participated in such a study 30 days prior to screening
Subject without a compatible smartphone
Subject not proficient with written and spoken English
Any other disorder or condition that, in the opinion of the investigator would pose a risk to subject safety or interfere with the study evaluation, procedures or completion
Participant has diminished decision-making capacity
Admitted to or planned discharge to a skilled nursing facility or rehabilitation facility (acute or subacute)
Clareo Health | Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure
